Clinical trials
Attention Deficit Disorder with Hyperactivity trials in the United Kingdom with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 3 |
| 2021 | 2 |
| 2022 | 1 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
| Unknown status | 6 |
| Active, not recruiting | 1 |
| Enrolling by invitation | 1 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| King's College London | 6 |
| University of Nottingham | 2 |
| University of Sheffield | 2 |
| North Essex Partnership NHS Foundation Trust | 1 |
| Northumbria University | 1 |
| Nottinghamshire Healthcare NHS Trust | 1 |
| South London and Maudsley NHS Foundation Trust | 1 |
| St Mary's University College | 1 |
| St. Mary's University, Twickenham | 1 |
| Swansea University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Attention Deficit Disorder with Hyperactivity | 21 |
| Autistic Disorder | 2 |
| Anxiety Disorders | 1 |
| Autism Spectrum Disorder | 1 |
| Brain Injuries | 1 |
| Dyslexia | 1 |
| Marijuana Abuse | 1 |
| Stroke | 1 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.